Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads
© Getty Images

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpLiz Cheney: 'Send her back' chant 'inappropriate' but not about race, gender Booker: Trump is 'worse than a racist' Top Democrat insists country hasn't moved on from Mueller MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinDemocrats pledge to fight Trump detention policy during trip to border Dems open to killing filibuster in next Congress Democrats warm to idea of studying reparations MORE (D-Ill.), Kirsten GillibrandKirsten Elizabeth GillibrandHarris faces pressure to define policy proposals Democratic strategist predicts most 2020 candidates will drop out in late fall The Hill's 12:30 Report: Trump hits media over 'send her back' coverage MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanFinding a path forward to end surprise medical billing Trump's new labor chief alarms Democrats, unions Second ex-Senate staffer charged in aiding doxxing of GOP senators MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownThe Hill's Morning Report - A raucous debate on race ends with Trump admonishment On The Money: Senators unload on Facebook cryptocurrency | Tech giants on defensive at antitrust hearing | Democrats ask Labor Department to investigate Amazon warehouses Hillicon Valley: Senators unload on Facebook cryptocurrency plan | Trump vows to 'take a look' at Google's ties to China | Google denies working with China's military | Tech execs on defensive at antitrust hearing | Bill would bar business with Huawei MORE (D-Ohio) and Angus KingAngus Stanley KingPoll: McConnell is most unpopular senator Senate panel advances Pentagon chief, Joint Chiefs chairman nominees Overnight Defense: Highlights from Defense pick's confirmation hearing | Esper spars with Warren over ethics | Sidesteps questions on Mattis vs. Trump | Trump says he won't sell F-35s to Turkey MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.